abstract |
The present invention relates to an aniline pyrimidine derivative or a pharmaceutically acceptable salt thereof as an EGFR inhibitor, specifically, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, or a pharmaceutical thereof. The present invention relates to compositions and methods and uses for treating EGFR-mediated diseases. |